Mertiva AB

About Us

Mertiva AB (former Diamyd Medical) primarily consists of holdings in liquid assets and holdings in Protein Sciences Corporation and Mercodia AB. Mertiva (former Diamyd Medical) shares are listed on Nasdaq OMX (segment Small Cap) in Stockholm (ticker: DIAM B) and on OTCQX in the US (ticker: DMYDY) administered by the Pink OTC Markets and the Bank of New York Mellon (PAL).

Pick a time period -

Tags ( Active)

All Regulatory Non-Regulatory

Quarterly Report II 11/12

Wed, Apr 04, 2012 08:30 CET

September 2011 – February 2012 Quarterly Report Diamyd Medical AB (publ), fiscal year 2011/2012(www.omxgroup.com ticker: DIAM B; www.otcqx.com ticker: DMYDY) Reporting period December 1, 2011 – February 29, 2012 · Group net sales amounted to MSEK 0.6 (114.5) · Profit before tax amounted to MSEK -13.9 (73.7) · Earnings per share after dilution were SEK -0.46 (2.51) · The Group’s liquid assets and short term investments amounted to MSEK 408 (474) as of February 29, 2012 First half year, September 1, 2011 – February 29, 2012 · Group net sales amounted to MSEK 0.6 (

Quarterly Report II 09/10

Wed, Apr 28, 2010 08:30 CET

Quarterly report, Stockholm, April 28, 2010 September 1, 2009 - February 28, 2010 Second quarter report for Diamyd Medical AB (publ), fiscal year 2009/2010 (www.omxgroup.com ticker: DIAM B; www.otcqx.com ticker: DMYDY Second quarter December 1, 2009 – February 28, 2010 - Group net sales for the second quarter was MSEK 0.2 (0.8) - Loss before tax for the second quarter was MSEK -26.6 (-15.4) - Earnings per share after dilution for the second quarter were SEK -0.2 (-0.7) First half year September 1, 2009 – February 28, 2010 - Group net sales for the first half year was MSEK 1.4 (0.9) - Loss

There are no items matching the current filter

There are no more items matching the current filter

Share

About Us

Quarterly Report II 11/12

Quarterly Report II 09/10

Media